RE:KEDRION.... No free lunch???If you look at the last finiacials you can see that all institutional holders including Consonance that was in during the steal have sold out. Also SALP, Thomvest shell company in the Cayman Islands, the majority holder has also been unloading to unsuspecting investors. This will ot end well for anyone invested here unless they are looking for easy capital losses that is.
wyndewest wrote: Liminal, managed by Thomvest, has sold the FDA approved Ryplazim drug to the Italian Biotechnology company' KEDRION' for almost nothing. That coveted technology is owned by Liminal who have shareholders. Those shareholders would want the best value possible if the technology is to be sold. That's how the stock market/business should work. So why did Thomvest give away Ryplazim for almost nothing?? Well, they hold the majority of shares for one thing although I think they are selling some of those shares when it suits them BUT here's the point: why would Kedrion be given a 'free lunch' ?? There is NO FREE LUNCH in life. There is always a price to be paid! Kedrion must be compensating Thomvest in some way. Thomvest is too smart to be giving away such valuable technology. Kedrion has branches all over the world. One in particular caught my eye: SWITZERLAND. Now that might be a convenient country to complete the Ryplazim transaction with Thomvest (owned by Peter Thomson of the Canadian billionaire Thomson family). We don't know yet if it will play out this way and perhaps we will never know because it will be off Liminal's books but it is fair to say the 'Ryplazim transaction' reeks of unethical/nefarious behaviour on the part of Thomvest. I sure do feel sorry for the Liminal shareholderss that bought 'THE RIGHTS OFFERr' from Thomvest at a much higher price than the stock trades at today and most likely will NEVER go back to that share price again.